No recent analyst price targets found for MMIRF.
Latest News for MMIRF
MedMira Reports Third Quarter Results FY2026
HALIFAX, NS / ACCESS Newswire / June 29, 2026 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2026. Corporate update During Q3 FY2026, the Company continued to advance the regulatory approval process for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test (Multiplo® TP/nTP).
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for MMIRF.
Senate Trading
No Senate trades found for MMIRF.
U.S. House Trading
No House trades found for MMIRF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.